ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

NCI CTCAE v5.0 hypertension

NCI CTCAE v5.0 hypertension
Adverse event Grade 1 Grade 2 Grade 3 Grade 4 Grade 5
Hypertension

Adult: Systolic BP 120 to 139 mmHg or diastolic BP 80 to 89 mmHg


Pediatric: Systolic/diastolic BP >90th percentile but <95th percentile


Adolescent: BP ≥120/80 even if <95th percentile

Adult: Systolic BP 140 to 159 mmHg or diastolic BP 90 to 99 mmHg if previously WNL; change in baseline medical intervention indicated; recurrent or persistent (≥24 hours); symptomatic increase by >20 mmHg (diastolic) or to >140/90 mmHg; monotherapy indicated or initiated


Pediatric and adolescent: Recurrent or persistent (≥24 hours) BP >ULN; monotherapy indicated; systolic and/or diastolic BP between the 95th percentile and 5 mmHg above the 99th percentile


Adolescent: Systolic between 130 to 139 or diastolic between 80 to 89 even if <95th percentile

Adult: Systolic BP ≥160 mmHg or diastolic BP ≥100 mmHg; medical intervention indicated; more than one drug or more intensive therapy than previously used indicated


Pediatric and adolescent: Systolic and/or diastolic >5 mmHg above the 99th percentile
Adult and pediatric: Life-threatening consequences (eg, malignant hypertension, transient or permanent neurologic deficit, hypertensive crisis); urgent intervention indicated Death
Hypertension is characterized by a pathological increase in blood pressure.
NCI CTCAE: National Cancer Institute Common Terminology Criteria for Adverse Events; BP: blood pressure; WNL: within normal limits; ULN: upper limit of normal.
Reproduced from: Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0, November 2017, National Institutes of Health, National Cancer Institute. Available at: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf (Accessed March 27, 2018).
Graphic 87347 Version 7.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟